Mindfulness and Biofeedback Ease Migraine Pain but Do Not Reduce Attack Frequency

Mindfulness-based interventions and biofeedback do not significantly reduce objective migraine attack frequency compared to control conditions, but they do demonstrate statistically significant efficacy in alleviating subjective pain intensity, mitigating headache-related disability, and enhancing quality of life in adult migraine patients. These findings emerge from a comprehensive systematic review and meta-analysis investigating non-pharmacological self-regulation approaches for adult migraine management.

Published in Frontiers in Neuroscience under the autonomic neuroscience section, the study evaluated the clinical efficacy of both mindfulness programs and biofeedback modalities. The research protocol adhered strictly to the PRISMA reporting guidelines and was prospectively registered in the international prospective register of systematic reviews, PROSPERO, under the registration identifier CRD420261381587.

To assemble the evidence base, the investigative team carried out a structured literature search across the PubMed, Scopus, and PsycInfo electronic databases. The search focused on English-language randomized controlled trials published over a ten-year window extending from May 2016 to May 2026. Ultimately, seven randomized controlled trials encompassing a collective cohort of 535 adult participants met the predefined eligibility criteria, with study quality and potential risk of bias evaluated using the Cochrane Risk of Bias 2 (RoB 2) tool.

When examining primary clinical attack metrics, the pooled meta-analysis for headache frequency across six included studies revealed no statistically significant differences between experimental intervention groups and control conditions.

Conversely, the review documented robust, statistically significant improvements favoring the intervention cohorts across subjective physical and functional parameters. Headache-related functional disability, quantified across six clinical trials utilizing the standardized Headache Impact Test (HIT-6) scale, demonstrated a statistically significant reduction, yielding a mean difference of -2.28 points (95% confidence interval: -4.47 to -0.08; p = 0.04). Similarly, pooled data from three studies examining pain intensity demonstrated a statistically significant decrease among patients practicing mindfulness or biofeedback, showing a standardized mean difference of -0.39 (95% confidence interval: -0.64 to -0.14; p = 0.002).

Health-related quality of life also registered substantial gains across the experimental cohorts. Synthesizing data across three studies revealed a statistically significant improvement favoring the intervention groups, with a mean difference of +5.21 points (95% confidence interval: 1.95 to 8.47; p = 0.002). However, affective psychological distress outcomes did not show corresponding divergence between study arms, with pooled analyses detecting no statistically significant differences between groups for either anxiety (p = 0.30) or depression (p = 0.88).

In evaluating these patterns, the authors concluded that while mindfulness-based interventions and biofeedback fail to decrease the objective frequency of migraine attacks, their proven capacity to diminish pain severity, lessen day-to-day functional disruption, and restore quality of life confirms their clinical utility as valuable complementary self-regulation and coping strategies. The researchers further noted that the absence of significant differences in psychological distress measures may partly reflect subclinical baseline depression scores among episodic migraine cohorts, active-comparator effects within control designs, and heterogeneity among the measurement instruments utilized across trials.

The international collaboration brought together researchers from Spain and Taiwan, uniting specialists across physiotherapy, nursing, neurology, medicine, and clinical psychology. The investigative effort was led by Chaimae Zahri Haidar alongside corresponding author Jose I. Recio-Rodriguez from the University of Salamanca and the Instituto de Investigación Biomédica de Salamanca. The team also included Natalia Sanchez-Aguadero and Irene A. Garcia-Yu from the university and biomedical institute, neurologist Luis López-Mesonero from the stroke unit at the Complejo Asistencial Universitario de Salamanca, and Taipei Medical University researchers Hsin-Chien Lee and Hsueh-Chen Lu. Following initial submission on 12 August 2026, the paper underwent peer review and was accepted for publication on 29 October 2026.

While six of the trials supplied sufficient quantitative data to evaluate headache attack frequency and functional impairment using the HIT-6 instrument, only three trials contributed to the pooled analyses for subjective pain intensity and health-related quality of life.

Categorized within the fields of autonomic neuroscience, psychology, and pain management, the study was published as an open-access report under a Creative Commons Attribution license.

Subject of Research: Efficacy of mindfulness-based interventions and biofeedback in adult migraine management

Article Title: Efficacy of mindfulness-based interventions and biofeedback for migraine management: a systematic review and meta-analysis of randomized controlled trials

Article References: Zahri-Haidar, C., Recio-Rodriguez, J. I., Sanchez-Aguadero, N., Lee, H.-C., López-Mesonero, L., Lu, H.-C., & Garcia-Yu, I. A. (2026). Efficacy of mindfulness-based interventions and biofeedback for migraine management: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Neuroscience, 20, Article 1965907. https://doi.org/10.3389/fnins.2026.1965907

Image Credits: AI Generated

DOI: 10.3389/fnins.2026.1965907

Keywords: migraine, mindfulness-based interventions, biofeedback, headache frequency, pain intensity, headache-related disability, HIT-6 scale, quality of life, systematic review, meta-analysis, randomized controlled trials, PRISMA, Cochrane RoB 2, neurology, anxiety, depression, self-regulation